Drugs / Z650
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 11 trial | ||||||
| Phase 1 | NCT04131192 | Nov 2019 → Sep 2021 | malignant pancreatic neoplasm | Sunshine Lake Pharma Co., Ltd. | Terminated | No outcome recorded |
| Phase 1/21 trial | ||||||
| Phase 1/2 | NCT03888092 | Aug 2017 → Dec 2022 | esophageal squamous cell carcinoma | Sunshine Lake Pharma Co., Ltd. | Completed | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Z650 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04131192 ↗ |